期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
分子排阻色谱法测定马罗匹坦注射液中磺丁倍他环糊精钠的含量 被引量:1
1
作者 于晓辉 赵富华 +3 位作者 董玲玲 马秋冉 杨星 杨秀玉 《安徽农业科学》 CAS 2015年第21期154-156,共3页
[目的]建立马罗匹坦注射液中磺丁倍他环糊精钠的含量测定方法。[方法]采用分子排阻色谱法,以0.1 mol/L硝酸钾溶液-甲醇(65∶35)为流动相,采用分子排阻色谱法检测马罗匹注射液中磺丁倍他环糊精钠的含量。[结果]磺丁倍他环糊精钠与相邻... [目的]建立马罗匹坦注射液中磺丁倍他环糊精钠的含量测定方法。[方法]采用分子排阻色谱法,以0.1 mol/L硝酸钾溶液-甲醇(65∶35)为流动相,采用分子排阻色谱法检测马罗匹注射液中磺丁倍他环糊精钠的含量。[结果]磺丁倍他环糊精钠与相邻峰的分离度均大于3.0;在6-180μg范围内峰面积与浓度呈良好的线性关系(r=0.999 9,n=8);在80%、100%、120%3种添加水平下的平均回收率分别为95.96%(RSD=0.5%,n=3)、98.41%(RSD=0.4%,n=3)、97.77%(RSD=0.5%,n=3)。[结论]该方法专属性强、准确度好、适应范围宽,可作为马罗匹坦注射液中磺丁倍他环糊精钠的含量测定方法。 展开更多
关键词 磺丁倍他环糊精钠 马罗匹坦注射液 分子排阻色谱法
在线阅读 下载PDF
Supramolecular Complexes of Ultrashort Cationic Lipopeptides with Cyclodextrins:Improved Selectivity and Therapeutic Potential
2
作者 Chiara Bellini Unai Atxabal +7 位作者 Szilvia Bősze Orsolya Dobay Andrea Horváth Imola Cs.Szigyártó Tamás Beke-Somfai Jesús Jiménez-Barbero István Puskás Kata Horváti 《Aggregate》 2025年第4期167-187,共21页
In the last decade,the rise of antibiotic resistance has heightened interest in antimicrobial peptides and lipopeptides as promising alternatives to conventional antibiotics because of their lower propensity to develo... In the last decade,the rise of antibiotic resistance has heightened interest in antimicrobial peptides and lipopeptides as promising alternatives to conventional antibiotics because of their lower propensity to develop resistance.However,lipopeptides often show undesired cytotoxicity due to their non-selective membrane disruptive effect,and their limited aqueous solubility represents a matter of concern from a pharmaceutical point of view.This study demonstrates a panel of ultrashort cationic lipopeptides(USCLs)consisting of a tetrapeptide(L1),originated from buforin II,coupled with saturated fatty acids of different lengths.Our results highlight that the 16-carbon fatty acid lipopeptide(Pal-L1)exhibits relevant antibacterial activity against multiresistant Staphylococcus aureus strain.However,the formation of heterogenic aggregates in cell culturemedium and toxic effects on human cells were also observed.Pal-L1 formulation with the randomly methylatedα-cyclodextrin(RAMEA)and the sulfobutylether-β-cyclodextrin(SBECD)has resulted in a production of ultralow-sized molecular dispersion systems and reduced lipopeptide toxicity without compromising its antimicrobial activity.With titration 1H-NMR,2D NMR experiments,together with molecular dynamics simulations,we described the size,structure,stoichiometry,and dissociation constant of the supramolecular complexes.Interactions of neutral and negatively chargedmodel liposomes with Pal-L1 lipopeptide in the presence or absence of cyclodextrins serve an explanation for the membrane selectivity,and based on the results,we proposed a potential mechanism of action for the Pal-L1+cyclodextrin complexes on different biological membranes.Overall,our model characterization points out that cyclodextrin formulation improves the therapeutical applicability of lipopeptides. 展开更多
关键词 buforin CYCLODEXTRIN LIPOPEPTIDE MRSA RAMEA sbecd
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部